Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
LIPLASOME PHARMA ApS
APS
Active
Advertising protection
CVR 29428514
Tabletvej 1, 7100
Vejle
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2006 · 20 years old
2 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
LIPLASOME PHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Related companies
Company hierarchy
Bagger-Sørensen & Co. A/S
90%
VECATA INVEST ApS
90%
LIPLASOME PHARMA ApS
(this company)
Board network connections
Board members of LIPLASOME PHARMA ApS also hold positions in
171
other companies.
Person
Role here
Other companies
Steen Bagger-Sørensen
Board of Directors
62 companies
Many roles
Claus Bagger-Sørensen
Board of Directors
56 companies
Many roles
Torben Brøgger-Mikkelsen
Board of Directors
17 companies
Many roles
Hans-Henrik Horsted Eriksen
Chief Executive Officer
15 companies
Many roles
Peter Buhl
Board of Directors
9 companies
Many roles
John Riis Mortensen
Chairman
8 companies
Many roles
Torben Vilsgaard
Board of Directors
2 companies
Holger Bagger-Sørensen
Chairman
2 companies
More on LIPLASOME PHARMA ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
People & ownership →
Management, board and shareholder breakdown
Bagger-Sørensen & Co. A/S
LIPLASOME PHARMA ApS